Reem Al‐Saadi

1.3k total citations
22 papers, 403 citations indexed

About

Reem Al‐Saadi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Reem Al‐Saadi has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Reem Al‐Saadi's work include Renal and related cancers (15 papers), Renal cell carcinoma treatment (7 papers) and Tumors and Oncological Cases (6 papers). Reem Al‐Saadi is often cited by papers focused on Renal and related cancers (15 papers), Renal cell carcinoma treatment (7 papers) and Tumors and Oncological Cases (6 papers). Reem Al‐Saadi collaborates with scholars based in United Kingdom, Qatar and France. Reem Al‐Saadi's co-authors include Kathy Pritchard‐Jones, Janet Shipley, Richard D. Williams, Robert Huddart, Gordan Vujanić, Richard S. Houlston, Chris Jones, Brenda Summersgill, Karim Labrèche and Peter Broderick and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Reem Al‐Saadi

17 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reem Al‐Saadi United Kingdom 11 260 190 117 80 47 22 403
C. Elizabeth Hook United Kingdom 7 116 0.4× 86 0.5× 145 1.2× 37 0.5× 88 1.9× 14 333
Mazen A. Ghanem Egypt 11 200 0.8× 140 0.7× 52 0.4× 72 0.9× 29 0.6× 24 375
Eleonora Biasin Italy 10 62 0.2× 130 0.7× 50 0.4× 97 1.2× 28 0.6× 13 367
Zehra Ordulu United States 12 130 0.5× 88 0.5× 67 0.6× 91 1.1× 46 1.0× 36 559
Mariola Iliszko Poland 12 117 0.5× 189 1.0× 88 0.8× 16 0.2× 44 0.9× 27 363
Rodrigo B. Interiano United States 10 186 0.7× 133 0.7× 34 0.3× 55 0.7× 88 1.9× 15 349
Sierra Li United States 5 492 1.9× 285 1.5× 32 0.3× 120 1.5× 30 0.6× 5 576
Rose B. McGee United States 9 120 0.5× 62 0.3× 71 0.6× 138 1.7× 81 1.7× 29 470
Turki Al‐Hussain Saudi Arabia 10 130 0.5× 188 1.0× 82 0.7× 11 0.1× 23 0.5× 33 344
A Uyttebroeck Belgium 7 108 0.4× 153 0.8× 26 0.2× 139 1.7× 16 0.3× 12 276

Countries citing papers authored by Reem Al‐Saadi

Since Specialization
Citations

This map shows the geographic impact of Reem Al‐Saadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reem Al‐Saadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reem Al‐Saadi more than expected).

Fields of papers citing papers by Reem Al‐Saadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reem Al‐Saadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reem Al‐Saadi. The network helps show where Reem Al‐Saadi may publish in the future.

Co-authorship network of co-authors of Reem Al‐Saadi

This figure shows the co-authorship network connecting the top 25 collaborators of Reem Al‐Saadi. A scholar is included among the top collaborators of Reem Al‐Saadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reem Al‐Saadi. Reem Al‐Saadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Saadi, Reem, Rhoikos Furtwängler, Norbert Graf, et al.. (2025). The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study. Pediatric Blood & Cancer. 72(4). e31580–e31580.
2.
3.
Watson, Tom A., Mark Powis, Gordan Vujanić, et al.. (2024). Multimodality detection of tumour rupture in children with Wilms tumour. Pediatric Blood & Cancer. 71(11). e31226–e31226.
4.
Chandler, Jennifer C., Daniyal J. Jafree, Mary M. Ball, et al.. (2024). Single‐cell transcriptomics identifies aberrant glomerular angiogenic signalling in the early stages of WT1 kidney disease. The Journal of Pathology. 264(2). 212–227.
5.
D’Hooghe, Ellen, Rhoikos Furtwängler, Tanzina Chowdhury, et al.. (2023). Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020). Cancer. 129(12). 1930–1938. 2 indexed citations
6.
Jackson, Thomas J., Reem Al‐Saadi, Sally Vernon, et al.. (2023). Comparing routinely collected population level healthcare data to a prospective clinical study of Wilms Tumour in England. SHILAP Revista de lepidopterología. 2. 100114–100114.
7.
Vujanić, Gordan, Ellen D’Hooghe, Norbert Graf, et al.. (2021). Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK‐CCLG and GPOH studies. International Journal of Cancer. 149(6). 1332–1340. 11 indexed citations
8.
Fajardo, Raquel Dávila, Rhoikos Furtwängler, Martine van Grotel, et al.. (2021). Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol. Cancers. 13(5). 976–976. 4 indexed citations
9.
Powis, Mark, Gordan Vujanić, Tom A. Watson, et al.. (2021). Surgical management, staging, and outcomes of Wilms tumours with intravascular extension: Results of the IMPORT study. Journal of Pediatric Surgery. 57(4). 572–578. 8 indexed citations
10.
Pritchard‐Jones, Kathy, Jesper Brok, William Mifsud, et al.. (2021). Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant. Pediatric Nephrology. 37(4). 821–832. 9 indexed citations
11.
Nakata, Kayo, Richard D. Williams, Yoshiaki Kinoshita, et al.. (2021). Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan. Pediatric Blood & Cancer. 68(10). e29143–e29143. 8 indexed citations
12.
Treger, Taryn D., Tasnim Chagtai, Robert Butcher, et al.. (2018). Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors. Translational Oncology. 11(6). 1301–1306. 22 indexed citations
13.
Constantinidou, Anastasia, Joanna Selfe, Sergey Popov, et al.. (2016). Epigenetic modulation in well differentiated (WD) and dedifferentiated (DD) liposarcoma (LPS): a novel therapeutic approach. Annals of Oncology. 27. vi484–vi484. 3 indexed citations
14.
Selfe, Joanna, David Olmos, Reem Al‐Saadi, et al.. (2016). Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials. Pediatric Blood & Cancer. 64(7). e26386–e26386. 18 indexed citations
15.
Gilbert, Duncan C., Reem Al‐Saadi, Khin Thway, et al.. (2015). Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma. Clinical Cancer Research. 22(5). 1265–1273. 18 indexed citations
16.
Litchfield, Kevin, Brenda Summersgill, Shawn Yost, et al.. (2015). Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nature Communications. 6(1). 5973–5973. 132 indexed citations
17.
Williams, Richard D., Reem Al‐Saadi, Rachael Natrajan, et al.. (2011). Molecular profiling reveals frequent gain of MYCN and anaplasia‐specific loss of 4q and 14q in wilms tumor. Genes Chromosomes and Cancer. 50(12). 982–995. 38 indexed citations
18.
Williams, Richard D., Reem Al‐Saadi, Tasnim Chagtai, et al.. (2010). Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor. Clinical Cancer Research. 16(7). 2036–2045. 55 indexed citations
19.
Messahel, Boo, Richard D. Williams, Antonia Ridolfi, et al.. (2009). Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study. European Journal of Cancer. 45(5). 819–826. 39 indexed citations
20.
Hing, Sandra, et al.. (2007). Primary Pericardial Synovial Sarcoma Confirmed by Molecular Genetic Studies. Journal of Pediatric Hematology/Oncology. 29(7). 492–495. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Elizabeth Hook Breakdown of academic impact, for papers by Mazen A. Ghanem Breakdown of academic impact, for papers by Eleonora Biasin Breakdown of academic impact, for papers by Zehra Ordulu Breakdown of academic impact, for papers by Mariola Iliszko Breakdown of academic impact, for papers by Rodrigo B. Interiano Breakdown of academic impact, for papers by Sierra Li Breakdown of academic impact, for papers by Rose B. McGee Breakdown of academic impact, for papers by Turki Al‐Hussain Breakdown of academic impact, for papers by A Uyttebroeck
Rankless by CCL
2026